Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Three new cancer treatments are to be made available on the NHS in Scotland, as six drugs are given the green light for use.

FPA India urges urgent action on cancer prevention and early detection With breast cervical and oral cancers rising stronger screening awareness and HPV vaccination programs are crucial ...

Anderson Diagnostics & Labs, a trusted name in healthcare, proudly celebrates its 15th anniversary, marking a significant ...

The WHO report highlights that most cases of colorectal cancer are diagnosed in the later stages when treatment becomes more ...

Cancer prevention isn’t about drastic changes, it’s about small, positive lifestyle habits that improve your well-being. By ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Anderson Diagnostics & Labs marks its 15th anniversary, celebrating its growth from a single lab to seven PET centres across ...

H.C. Wainwright analyst Andres Y. Maldonado confirmed a Buy rating and a $75.00 price target on Corbus Pharmaceuticals (NASDAQ:CRBP), representing significant upside potential from the current price ...